Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has announced a Board of Directors meeting scheduled for November 13, 2026. The primary agenda is to consider and approve the Un-Audited Financial Results for the quarter and half-year ended September 30, 2026. Concurrently, the company will reopen its trading window for securities from November 16, 2026, following a closure from October 1 to November 15, 2026, for directors and designated persons.

Dishman Carbogen Amcis Limited has announced a Family Settlement Agreement (FSA) entered into by members of the Vyas family, who are promoters/members of the promoter group. The company is not a party to this agreement. The FSA aims to align ownership with management of the family's business interests, particularly in Dishman Carbogen Amcis, and to realign holdings in other entities. A key term involves a share purchase agreement where Adimans Technologies LLP will sell its entire 59.32% stake in the company to Aamanya AG. Following this, Mrs. Vyas will resign as a partner of Adimans LLP and potentially as a director of the company. Other family members may seek reclassification as public shareholders.

Dishman Carbogen Amcis Limited has announced an inter-se transfer of shares within its promoter group. Aamanya AG, the acquirer, will purchase the entire shareholding of Adimans Technologies LLP, the seller, comprising 9,30,02,442 equity shares representing 59.32% of the total paid-up share capital. This transaction, executed via a Share Purchase Agreement dated October 28, 2026, is exempt from open offer requirements under SEBI's SAST Regulations. The transfer is subject to customary conditions precedent. Importantly, this realignment will not alter the aggregate promoter and promoter group shareholding, nor will it impact the management or control of the company, which will continue to reside with the Promoter Group.

Dishman Carbogen Amcis Ltd has approved the allotment of 3,800 Senior, Secured, Rated, Listed, Redeemable, Taxable, Transferable Non-Convertible Debentures (NCDs) aggregating to ₹38,00,00,000 (₹38 Crore). The NCDs have a face value of ₹1,00,000 each and were issued at par through private placement. The maturity date for these debentures is April 15, 2028, or any Early Redemption Date. This issuance is part of the company's financing strategy.

Dishman Carbogen Amcis Ltd announced its Board of Directors has approved the issuance of up to 3,800 Senior, Secured, Rated, Listed, Redeemable, Taxable, Transferable Non-Convertible Debentures (NCDs) with a face value of Rs. 1,00,000/- each, aggregating up to Rs. 38,00,00,000/- (Rs. 38 Crores) on a private placement basis. The NCDs will have a coupon rate of 10.00% p.a., with quarterly interest payments and bullet payment on maturity in 18 months from allotment. The issue will be secured by a 1.10x security cover, backed by a first-ranking charge over non-agriculture land of promoter entity Dishman Infrastructure Limited (DIL). This security will be substituted with a 100% cash margin in the form of an FD lien in favor of the Debenture Trustee, as DIL may require the land for its commercial purposes. The company will seek stock exchange approval for this modification. Additionally, the Board approved modifications to the security in respect of existing Tranche II NCDs worth ₹15 Crore.

Dishman Carbogen Amcis Ltd has announced that its Board of Directors will convene on October 7, 2026. The primary agenda items include considering and approving a proposal for fund raising through the issuance of Non-Convertible Debentures via private placement. Additionally, the board will discuss modifications to the security of the Company's Tranche II Non-Convertible Debentures, totaling ₹15 Crore, which were allotted on September 28, 2026.

Dishman Carbogen Amcis Ltd announced the allotment of 1,500 Senior, Secured, Rated, Listed, Redeemable, Transferable, Taxable Non-Convertible Debentures (NCDs) worth ₹15 Crores. The allotment was approved by the Management Committee of the Board of Directors on September 28, 2026. These NCDs have a face value of ₹1,00,000 each and a final maturity date of March 28, 2028, or any early redemption date. The issuance was conducted through private placement.

Dishman Carbogen Amcis Ltd has announced the closure of its trading window for all directors, designated persons, and their immediate relatives. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and will be effective from October 1, 2026. The trading window will reopen 48 hours after the announcement of the company's un-audited financial results for the quarter and half-year ending September 30, 2026. This measure is a standard practice to prevent insider trading during periods leading up to financial result disclosures.

Dishman Carbogen Amcis Ltd announced that its wholly-owned subsidiary, CARBOGEN AMCIS AG's manufacturing site in Vionnaz, Switzerland, has successfully completed a U.S. Food and Drug Administration (FDA) inspection. The inspection concluded without any Form 483 observations, highlighting the company's strong commitment to quality standards across its global operations. This successful audit reinforces the regulatory compliance of the company's facilities, which are approved by major regulatory agencies worldwide.

Dishman Carbogen Amcis Ltd has announced its 19th Annual General Meeting (AGM) scheduled for September 30, 2026, to be held via Video Conferencing. The company has also released its Annual Report for the financial year 2025-26, which includes the Corporate Governance Report, Management Discussion & Analysis, and Business Responsibility and Sustainability Report. Shareholders can participate in the AGM and vote electronically through remote e-voting and e-voting during the AGM via the CDSL platform. The cut-off date for determining voting eligibility is September 23, 2026. The Annual Report is available on the company's website.